Lung Non-Squamous Non-Small Cell Carcinoma

Lung Non-Squamous Non-Small Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

408 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 93
Recruiting: 47
Ph III recruiting: 15
Growth YoY: —
Industry share: 39%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (55)

clinicaltrialsPublishedShowing 401–408 of 408 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00042835	Erlotinib and Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Inoperable Stage III Non-Small Cell Lung Cancer	terminated	Phase 1	48	National Cancer Institute (NCI)NIH	1	Feb 1, 2013	clinicaltrials
NCT00005838	Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery	completed	Phase 3	756	National Cancer Institute (NCI)NIH	1	Jan 23, 2013